osasuyi iyasere retweeted
For the first time, we have randomized trial evidence comparing preparation for dialysis with conservative kidney management in older people approaching kidney failure.
On November 5, the first results of the Prepare for Kidney Care randomized controlled trial will be presented in an ISN webinar.
445 participants. 31 UK kidney units. An average 4.5 years of follow-up.
This is one to put in your calendar.
Register now: bit.ly/4yvfvEn
@fjcaskey @FionaCLoud @BarnyHole @jardine_meg
osasuyi iyasere retweeted
Important info for older people considering transplant. Qualitative study to follow @Kidney_Research @UKKidney @amarpreet_thind @mkwillicombe
osasuyi iyasere retweeted
👉 Over 7 million people live with kidney disease in the UK - yet it was barely mentioned in the Government’s 10-year health plan.
It’s time for action.
Sign our open letter to the Prime Minister calling for a national strategy for CKD and help build a better future for kidney patients: bit.ly/PMCKDLttr
@kidneycareuk, @Kidney_Research, @NKF_UK and @UKKidney are all on board. Are you?
#CKDStrategy
osasuyi iyasere retweeted
📣We're all set for our first-ever PKD Info & Support Day in Leicester this Sat, 28 June – and we can’t wait! 🎉
A packed agenda, expert clinicians, and the chance for our PKD families to meet new friends.
📍Next up: Exeter, 8 Nov – save the date! Make sure you’re signed up to receive our e-news so you never miss updates on upcoming in-person and online events>bit.ly/PKDEnews
osasuyi iyasere retweeted
Implementation and Evaluation of a Smartphone-Based Application for Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients:
A Prospective Feasibility Cohort Study and Collaborative Effort of Patients and the Peritoneal Dialysis Team
doi.org/10.1093/ckj/sfaf102
osasuyi iyasere retweeted
🟡💜It's World Kidney Day! 💜🟡
Today, we shine a light on the 7+ million people living with kidney disease, the incredible organ donors, families, and healthcare professionals who support them, and the countless others at risk but unaware.
👊Help raise awareness about the importance of our kidneys and stand with those facing kidney disease. Please share!
#KidneysMatter #WorldKidneyDay #ADPKD #ARPKD
osasuyi iyasere retweeted
📢 It's #WorldKidneyDay & it's time for EVERYONE to take their #BloodyAmazingKidneys more seriously!
We're dedicated to raising awareness of the #BloodyAmazing job our #Kidneys do everyday, & to help identify those most at risk of developing #CKD 👇 kidneycareuk.org/bloodyamazi…
osasuyi iyasere retweeted
Time restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trial
doi.org/10.1093/ckj/sfaf069
osasuyi iyasere retweeted
New Guidelines Set to Transform PKD Care!
The first-ever KDIGO guidelines for autosomal dominant polycystic kidney disease (ADPKD) are here.
Developed over a decade with input from healthcare professionals, researchers, and patient groups, including PKD Charity, they set a new standard for diagnosis, prognosis and treatment - ensuring patients receive the right care, at the right time.⏳
View and download guidelines: bit.ly/PKDKDIGO25
osasuyi iyasere retweeted
📢Looking for guidance on how to best manage Polycystic Kidney Disease (PKD)?
Join us at our Leicester Information & Support Day, hosted by Kidney Specialist Dr Osasuyi Iyasere.
Attendance is free to patients, family members and healthcare professionals, including lunch and refreshments throughout the day!
Register 👉bit.ly/LeicPKD25
osasuyi iyasere retweeted
Individuals receiving hemodialysis are susceptible to QT interval–prolonging medication–related cardiac complications. This study found ondansetron initiation is associated with higher 10-day sudden cardiac death risk bit.ly/JASN0336
@UNCKidney
osasuyi iyasere retweeted
📢New study finds 12-week cognitive & physical training program during HD sessions significantly improves cognitive function & mobility in patients. Integrated interventions show promise in mitigating functional declines & enhancing quality of life. 👟
🔗doi.org/10.1016/j.ekir.2024.…
osasuyi iyasere retweeted
Inequities in access to #CKD treatment exist. Through advocacy efforts, awareness-raising activities, and strengthening health systems, we can make a real difference for people living with kidney disease.
worldkidneyday.org/2024-camp…
#WorldKidneyDay #KidneyHealthforAll
osasuyi iyasere retweeted
Great to see results of the @wilkiemart @simonsingingdoc @DrFothers PD Catheter Study a sub-study of #PDOPPS reported. Highlights the importance of the percutaneous PD access insertion pathway @ispd #peritonealdialysis @KIReports @ArborResHealth #homedialysis
osasuyi iyasere retweeted
Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients
👉bit.ly/3AKGcZh👈
osasuyi iyasere retweeted
Registration is now open for the @YAKidneyGroup annual residential weekend. This free event is for young people aged 18-30 who have a kidney condition: bit.ly/3LiKR9C
osasuyi iyasere retweeted
📣 Guideline update 📣
The #Vascular Access for #Haemodialysis guideline is now available in an accessible style written by a multiprofessional team:
📖 bit.ly/3o3mIfi
🔹Variation in characteristics
🔹Importance of patient choice
🔹Individualised clinical approach
osasuyi iyasere retweeted
Anticoagulation management in #haemodialysis patients with #atrialfibrillation
academic.oup.com/ndt/article… – at Birmingham, England
osasuyi iyasere retweeted
In all groups - response better with younger age, prior infection and more vaccines.
Triple immunosuppression in SOTs & anti-CD20 in autoimmune/cancer cohorts associated with non-response.
No abs = approx 1 in 5.
Correlation with infection/outcome - to follow soon.
osasuyi iyasere retweeted
📢 The new PKD App is now available to download! Ideal for the newly diagnosed/early stages of ADPKD, it offers:
✔️ Credible information & accredited health advice
✔️ Practical tips for everyday life
✔️ Links to trusted further information & support
More👉bit.ly/PKDApp





























